Furthermore, the European Randomised Study of Screening for Prostate Cancer trial also estimated that, when PSA is used alone as a screening tool for PCa, almost 50% of patients were over-diagnosed (12). The gene discussed is KLK3; the disease is posterior cortical atrophy.